Selamectin Topical Solution 45 mg (60 mg/mL) 0.75 mL 3ct (Cats 5.1-15 lb) (ZyVet)

ZyVet™️ Selamectin Topical Parasiticide is available as a colorless to yellow, ready-to-use solution in single-dose tubes for the topical treatment of cats eight weeks of age and older.

• Therapeutically equivalent to the pioneer drug, but at a more affordable price

In cats, Selamectin is indicated for:

• Prevention and control of flea infestations
• Prevention of heartworm disease caused by Dirofilaria immitis
• Treatment and control of ear mite infestations
• Treatment and control of roundworm and intestinal hookworm

Important Safety Information: Not for human use. Keep out of reach of children. In humans, Selamectin may be irritating to skin and eyes. Do not use in sick, debilitated or underweight animals. Do not massage the product into the skin. Due to alcohol content, do not apply to broken skin. Avoid contact between the product and fingers. Do not apply when the haircoat is wet. Pre-Approval Clinical Trials: Following treatment with Selamectin, transient localized alopecia with or without inflammation at or near the site of application was observed in approximately 1% of 691 treated cats. Other signs observed (≤0.5% of 1743 treated cats and dogs) included vomiting, loose stool or diarrhea with or without blood, anorexia, lethargy, salivation, tachypnea, and muscle tremors. Post-Approval Experience (2021): The following adverse events are based on post-approval adverse drug experience reporting for selamectin. Not all adverse events are reported to FDA/CVM. It is not always possible to reliably estimate the adverse event frequency or establish a causal relationship to product exposure using this data. The following adverse events reported for dogs are listed in decreasing order of reporting frequency: Lethargy, vomiting, diarrhea, anorexia, generalized pruritus, seizures, application site reactions (including alopecia, lesions, erythema, pruritis, and inflammation), tremors, ataxia, death, and dermatitis. The following adverse events reported for cats are listed in decreasing order of reporting frequency: Application site reactions (including alopecia, lesions, erythema, pruritus, inflammation, vesicles, blisters, and excoriations), lethargy, anorexia, vomiting, death, generalized pruritus, diarrhea, ataxia, fever, generalized alopecia, tremors, hypersalivation, dermatitis, and seizures.

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian